Olverembatinib in Relapsed Philadelphia Chromosome-Positive B-cell Acute Lymphoblastic Leukemia: a Study of 5 Cases

Chunxiao Liu,Xiang Zhang,Liping Mao,Jiejing Qian,Feng Xiao,Xiujin Ye,Juying Wei,Xingnong Ye,Jie Jin,Wenjuan Yu
DOI: https://doi.org/10.1080/10428194.2023.2197534
2023-01-01
Leukemia & Lymphoma
Abstract:Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph + B-ALL) was one of high risky B-cell ALL subtypes that exhibits resistance to conventional chemotherapy [1,2
What problem does this paper attempt to address?